263 related articles for article (PubMed ID: 23970101)
21. Low expression of DAB2IP contributes to malignant development and poor prognosis in hepatocellular carcinoma.
Zhang X; Li N; Li X; Zhao W; Qiao Y; Liang L; Ding Y
J Gastroenterol Hepatol; 2012 Jun; 27(6):1117-25. PubMed ID: 22168621
[TBL] [Abstract][Full Text] [Related]
22. Overexpression of osteopontin is associated with intrahepatic metastasis, early recurrence, and poorer prognosis of surgically resected hepatocellular carcinoma.
Pan HW; Ou YH; Peng SY; Liu SH; Lai PL; Lee PH; Sheu JC; Chen CL; Hsu HC
Cancer; 2003 Jul; 98(1):119-27. PubMed ID: 12833464
[TBL] [Abstract][Full Text] [Related]
23. Expression and prognostic relevance of centromere protein A in primary osteosarcoma.
Gu XM; Fu J; Feng XJ; Huang X; Wang SM; Chen XF; Zhu MH; Zhang SH
Pathol Res Pract; 2014 Apr; 210(4):228-33. PubMed ID: 24440098
[TBL] [Abstract][Full Text] [Related]
24. Decreased expression of liver-type fatty acid-binding protein is associated with poor prognosis in hepatocellular carcinoma.
Wang B; Tao X; Huang CZ; Liu JF; Ye YB; Huang AM
Hepatogastroenterology; 2014; 61(133):1321-6. PubMed ID: 25436304
[TBL] [Abstract][Full Text] [Related]
25. Expression of NEDD9 in hepatocellular carcinoma and its clinical significance.
Lu P; Wang ZP; Dang Z; Zheng ZG; Li X; Zhou L; Ding R; Yue SQ; Dou KF
Oncol Rep; 2015 May; 33(5):2375-83. PubMed ID: 25812772
[TBL] [Abstract][Full Text] [Related]
26. Expression of hepatoma-derived growth factor in hepatocellular carcinoma.
Hu TH; Huang CC; Liu LF; Lin PR; Liu SY; Chang HW; Changchien CS; Lee CM; Chuang JH; Tai MH
Cancer; 2003 Oct; 98(7):1444-56. PubMed ID: 14508832
[TBL] [Abstract][Full Text] [Related]
27. Expression and prognostic value of ING3 in human primary hepatocellular carcinoma.
Yang HY; Liu HL; Tian LT; Song RP; Song X; Yin DL; Liang YJ; Qu LD; Jiang HC; Liu JR; Liu LX
Exp Biol Med (Maywood); 2012 Apr; 237(4):352-61. PubMed ID: 22550337
[TBL] [Abstract][Full Text] [Related]
28. Decreased expression of SOX6 confers a poor prognosis in hepatocellular carcinoma.
Guo X; Yang M; Gu H; Zhao J; Zou L
Cancer Epidemiol; 2013 Oct; 37(5):732-6. PubMed ID: 23731550
[TBL] [Abstract][Full Text] [Related]
29. Involvement of RhoA in progression of human hepatocellular carcinoma.
Wang D; Dou K; Xiang H; Song Z; Zhao Q; Chen Y; Li Y
J Gastroenterol Hepatol; 2007 Nov; 22(11):1916-20. PubMed ID: 17914970
[TBL] [Abstract][Full Text] [Related]
30. Overexpression of pituitary tumor transforming gene 1 in HCC is associated with angiogenesis and poor prognosis.
Fujii T; Nomoto S; Koshikawa K; Yatabe Y; Teshigawara O; Mori T; Inoue S; Takeda S; Nakao A
Hepatology; 2006 Jun; 43(6):1267-75. PubMed ID: 16628605
[TBL] [Abstract][Full Text] [Related]
31. Methylation of IRAK3 is a novel prognostic marker in hepatocellular carcinoma.
Kuo CC; Shih YL; Su HY; Yan MD; Hsieh CB; Liu CY; Huang WT; Yu MH; Lin YW
World J Gastroenterol; 2015 Apr; 21(13):3960-9. PubMed ID: 25852282
[TBL] [Abstract][Full Text] [Related]
32. Prognostic significance of FOXP1 as an oncogene in hepatocellular carcinoma.
Zhang Y; Zhang S; Wang X; Liu J; Yang L; He S; Chen L; Huang J
J Clin Pathol; 2012 Jun; 65(6):528-33. PubMed ID: 22422806
[TBL] [Abstract][Full Text] [Related]
33. Wilms' tumour 1 gene expression is increased in hepatocellular carcinoma and associated with poor prognosis.
Sera T; Hiasa Y; Mashiba T; Tokumoto Y; Hirooka M; Konishi I; Matsuura B; Michitaka K; Udaka K; Onji M
Eur J Cancer; 2008 Mar; 44(4):600-8. PubMed ID: 18255279
[TBL] [Abstract][Full Text] [Related]
34. [The expression and significance of heparanase and nm23-H1 in hepatocellular carcinoma].
Liu Y; Chen X; Peng S; Fang H; Wu Y; Peng C; Shi L; Bai M; Xu B; Wang J; Deng G
Zhonghua Yi Xue Za Zhi; 2002 Nov; 82(22):1553-6. PubMed ID: 12609066
[TBL] [Abstract][Full Text] [Related]
35. Correlation of gene expression of ATP-binding cassette protein and tyrosine kinase signaling pathway in patients with hepatocellular carcinoma.
Hoffmann K; Shibo L; Xiao Z; Longerich T; Büchler MW; Schemmer P
Anticancer Res; 2011 Nov; 31(11):3883-90. PubMed ID: 22110214
[TBL] [Abstract][Full Text] [Related]
36. Identification of the A kinase anchor protein 12 (AKAP12) gene as a candidate tumor suppressor of hepatocellular carcinoma.
Hayashi M; Nomoto S; Kanda M; Okamura Y; Nishikawa Y; Yamada S; Fujii T; Sugimoto H; Takeda S; Kodera Y
J Surg Oncol; 2012 Mar; 105(4):381-6. PubMed ID: 22052684
[TBL] [Abstract][Full Text] [Related]
37. Correlation and prognostic value of osteopontin and Bcl-2 in hepatocellular carcinoma patients after curative resection.
Deng B; Zhang XF; Zhu XC; Huang H; Jia HL; Ye QH; Dong QZ; Qin LX
Oncol Rep; 2013 Dec; 30(6):2795-803. PubMed ID: 24065086
[TBL] [Abstract][Full Text] [Related]
38. Overexpression of DEK gene is correlated with poor prognosis in hepatocellular carcinoma.
Yi HC; Liu YL; You P; Pan JS; Zhou JY; Liu ZJ; Zhang ZY
Mol Med Rep; 2015 Feb; 11(2):1318-23. PubMed ID: 25351213
[TBL] [Abstract][Full Text] [Related]
39. Increased expression of Wiskott-Aldrich syndrome protein family verprolin-homologous protein 2 correlated with poor prognosis of hepatocellular carcinoma.
Yang LY; Tao YM; Ou DP; Wang W; Chang ZG; Wu F
Clin Cancer Res; 2006 Oct; 12(19):5673-9. PubMed ID: 17020969
[TBL] [Abstract][Full Text] [Related]
40. Increased CDC20 expression is associated with development and progression of hepatocellular carcinoma.
Li J; Gao JZ; Du JL; Huang ZX; Wei LX
Int J Oncol; 2014 Oct; 45(4):1547-55. PubMed ID: 25069850
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
